Senior insider sale
President and COO at CG ONCOLOGY, INC. — senior position signals high conviction
$40.75M
545.92K shares
BELLETE AMBAW plans to sell 545.92K shares of CG ONCOLOGY, INC. valued at approximately $40.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Stock Option Exercise Cash | 52.44K | — |
| Total | 52.44K | ||
Completed
Units to sell
19.36K
Market value
$1.45M
Units to sell
25.99K
Market value
$1.97M
Units to sell
32.14K
Market value
$2.53M
Units to sell
50K
Market value
$3.81M
Units to sell
50K
Market value
$3.77M
Units to sell
9.25K
Market value
$696.1K
Units to sell
75K
Market value
$5.67M
Units to sell
25K
Market value
$1.84M
Units to sell
4.30K
Market value
$316.3K
Units to sell
50K
Market value
$3.63M
Units to sell
50K
Market value
$3.63M
Units to sell
50K
Market value
$3.59M
Units to sell
52.44K
Market value
$3.82M
Planned — Approximate Date
Units to sell
52.44K
Market value
$4.03M
Units
545.92K
Value
$40.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/14/2026 | 19.36K | $1.45M | — | Completed |
8/13/2026 | 25.99K | $1.97M | — | Completed |
8/12/2026 | 32.14K | $2.53M | — | Completed |
8/11/2026 | 50K | $3.81M | — | Completed |
8/10/2026 | 50K | $3.77M | — | Completed |
8/7/2026 | 9.25K | $696.1K | — | Completed |
8/6/2026 | 75K | $5.67M | — | Completed |
8/5/2026 | 25K | $1.84M | — | Completed |
7/29/2026 | 4.30K | $316.3K | — | Completed |
7/28/2026 | 50K | $3.63M | — | Completed |
7/27/2026 | 50K | $3.63M | — | Completed |
7/23/2026 | 50K | $3.59M | — | Completed |
7/15/2026 | 52.44K | $3.82M | — | Completed |
| Planned — Approximate Date | ||||
8/17/2026 | 52.44K | $4.03M | NASDAQ | Planned |
| Total | 545.92K | $40.75M | ||